It's a little unreal nominating Intuitive Surgical (Nasdaq: ISRG) as a bargain stock.
This is, after all, the stock that had a trailing P/E of 60 in 2004, when people called it overpriced. Of course, they were wrong, and it nearly tripled within a year.
And then in 2006, when the P/E topped 50, people again called it expensive. And it tripled a year later -- again.
Now it sports a P/E of less than 25.
Twenty-five!
This is a company that's seen trailing-12-month revenue increase 59% year over year. No matter what you think of high-growth stocks, that 25 P/E is pretty darn cheap.
It's the future, stupid
OK. So P/E isn't the best indicator of value. It's backward-looking, after all, and the future might not be so great for the surgical robot maker. Maybe.
Intuitive Surgical is dependent on hospitals for sales of the da Vinci robot, and right now investors don't seem to have much confidence that hospitals will keep spending as they have in the past. Just take a look at how much Intuitive Surgical and some of the other medical device makers have fallen this year.
| Company | Year-to-Date Return |
| Intuitive Surgical | (58.3%) |
| Kinetic Concepts (NYSE: KCI) | (59.4%) |
| Boston Scientific (NYSE: BSX) | (47.9%) |
| Medtronic (NYSE: MDT) | (40.6%) |
| SonoSite (Nasdaq: SONO) | (46.1%) |
| Stryker (NYSE: SYK) | (50%) |
| Zimmer (NYSE: ZMH) | (43.6%) |
Source: Morningstar as of Nov. 26, 2008.
So much for health care being a recession-proof industry.
Razors and blades
However, unlike many of the others in the table above, Intuitive Surgical works under the same business model as Gillette did with its razors. It sells the robots (the "razors") for a lower gross margin in order to make more money on the accessories (the "blades") at a higher margin.
The fringe benefit of this model is that there are more than 1,000 robots installed in countries all over the world. That's a lot of machines generating revenue from accessories, quarter after quarter. While the purchase of robots might slow down, people are still going to go in for surgeries, and the hospitals are still going to burn through accessories, even in bad economic times. After investing all that capital in the robot, hospitals aren't going to let it gather dust.
Of course, if hospitals do run into a credit crunch, Intuitive Surgical could always use some of its $400 million in cash and short-term investments to help hospitals finance their purchases (although based on previous management comments, it's more likely to sell to third-party leasing companies). This would help expand the installed base, which helps drive future revenue.
Even if sales do slip, it sounds like Chairman and CEO Lonnie Smith knows that the bottom line, which is driven by margins, is most important. In an interview with the Rule Breakers team, he said, "Fixed and variable costs are important to us. We are big believers in lean manufacturing and lean processes." (You can read the rest of the interview, and get the team’s take, by grabbing a free trial of the newsletter.)
Copyright © 2008 Universal Press Syndicate.
Recent comments
1 day 7 hours ago
1 day 14 hours ago
1 day 14 hours ago
1 day 17 hours ago
1 day 17 hours ago
2 days 11 hours ago
3 days 33 min ago
4 days 8 hours ago
1 week 1 day ago
1 week 1 day ago